Understanding OUR Cytokine-Based Immunotherapy Candidates Our dedication extends to advancing a robust portfolio of programs targeted at growing the horizons of cytokine-based immunotherapy, specifically for cancers where therapy solutions remain limited. Use the links below to learn far more about our portfolio of cytokine-based immunotherapy candidates. Discover Our Pipeline https://financefeeds.com/cboe-promotes-cto-tim-lipscomb-to-executive-vice-president/